News

The 2nd CRISPR Medicine Conference 2025

The 2nd CRISPR Medicine Conference | 7-11 April 2025 | Copenhagen, Denmark

- Jun. 26, 2024
News

Stay updated here

Tags

HashtagEvents

CLINICAL TRIALS
Advanced Primary or Secondary Peritoneal Tumors, (NCT07004647)
Sponsors:
Ruijin Hospital
IND Enabling
Phase I
Phase II
Phase III
Recurrent or Progressive High-grade Glioma, (NCT06737146)
Sponsors:
Suzhou Maximum Bio-tech Co., Ltd.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors, (NCT06912152)
Sponsors:
Zhejiang University
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine